As of 2025-07-09, the Fair Value of Phio Pharmaceuticals Corp (PHIO) is -7.05 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.50 USD, the upside of Phio Pharmaceuticals Corp is -382.08%.
With the market price of 2.50 USD and our fair value calculation, Phio Pharmaceuticals Corp (PHIO) is not a good investment. Investing in PHIO stocks now will result in a potential loss of 382.08%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -8.79 | -13.29 | -11.48 | -11.00 | -7.15 | -10.34 |
| YoY growth | 1.35% | -51.19% | 13.62% | 4.18% | 35.00% | 0.59% |
| Market Cap (mil) | 12.00 |
| P/E | |
| Forward P/E |
| EPS | -1.41 |
| Avg earnings growth rate | 0.59% |
| TTM earnings | -6.77 |